Esperion Therapeutics
ESPR
ESPR
113 hedge funds and large institutions have $366M invested in Esperion Therapeutics in 2015 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 38 increasing their positions, 30 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
15% less call options, than puts
Call options by funds: $3.62M | Put options by funds: $4.24M
25% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 28
Holders
113
Holding in Top 10
3
Calls
$3.62M
Puts
$4.24M
Top Buyers
| 1 | +$8.04M | |
| 2 | +$7.78M | |
| 3 | +$7.02M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.13M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$4.98M |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$7.3M | |
| 3 | -$5.58M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$5.05M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.98M |